Ranbaxy Laboratories reports net loss of Rs 842.23 crore in the September 2013 quarter
Sales decline 3.24% to Rs 1381.84 crore
Net loss of Ranbaxy Laboratories reported to Rs 842.23 crore in the quarter ended September 2013 as against net profit of Rs 552.19 crore during the previous quarter ended September 2012. Sales declined 3.24% to Rs 1381.84 crore in the quarter ended September 2013 as against Rs 1428.04 crore during the previous quarter ended September 2012. ParticularsQuarter EndedSep. 2013Sep. 2012% Var.Sales1381.841428.04 -3 OPM %-17.4316.19 -PBDT-307.62306.22 PL PBT-402.03261.86 PL NP-842.23552.19 PLPowered by Capital Market - Live News